Physician profile
Lee M Hlad
NPI 1508175449
$439,961.28
in general payments reported to CMS, 2019-2025
26 companies · $87K in 2025
The $87K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $17K · 2021: $49K · 2022: $57K · 2023: $131K · 2024: $49K · 2025: $87K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $188K · Travel and Lodging: $53K · Royalty Or License: $21K · Food and Beverage: $5,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $187,977.70 |
| Travel and Lodging | $52,872.96 |
| Royalty Or License | $20,782.30 |
| Food and Beverage | $5,058.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $291,424.09 | 2019-2025 | Portfolio, Monkey Rings, Apex 3d |
| Vilex LLC | $72,639.00 | 2019-2025 | Dynex, Redemption, Charcot |
| New Standard Device, LLC Dba Metalogix | $37,266.17 | 2022-2023 | |
| Treace Medical Concepts, INC. | $19,918.97 | 2023-2025 | |
| International Life Sciences | $11,203.90 | 2023 | Flexband, Flexband |
| Avitus Orthopaedics, INC. | $3,024.39 | 2019-2023 | |
| Acelrx Pharmaceuticals, INC. | $1,200.00 | 2020 | |
| Trimed, INC. | $1,000.00 | 2023 | |
| Organogenesis INC. | $615.83 | 2020-2021 | |
| Team 1, LLC | $482.09 | 2020 | |
| Cdc Medical LLC | $361.00 | 2019 | |
| Nuvasive Specialized Orthopedics, INC. | $163.94 | 2022 | |
| Stryker Corporation | $155.61 | 2019 | |
| Bone Support INC. | $154.86 | 2024 | Ceramentbone Void Filler, Cerament G |
| Bioventus LLC | $61.54 | 2022-2025 | Exogen Ultrasound Bone Healing System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $50.82 | 2024 | Biobrace 23mm |
| Horizon Therapeutics Plc | $44.01 | 2019-2021 | |
| Smith+Nephew, INC. | $32.72 | 2020-2021 | |
| Osteomed LLC | $25.74 | 2022 | |
| Abbott Laboratories | $24.15 | 2021 | |
| Aroa Biosurgery Incorporated | $23.76 | 2025 | |
| Bonalive INC | $21.33 | 2024 | |
| Medline Industries Lp | $18.88 | 2022 | |
| Sanara Medtech INC. | $18.23 | 2025 | Celleraterx |
| Tenex Health INC. | $17.01 | 2020 | |
| Paratek Pharmaceuticals, INC. | $13.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Hlad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.